Transplantation of encapsulated cells and tissues

Surgery

Volumn 121, Issue 1, 1997, Pages 1-9

  Lanza, Robert P ^a   Chick, William L ^a  

^a BioHybrid Technologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; AZATHIOPRINE; CYCLOSPORIN A; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; MICROSPHERE; RECOMBINANT CILIARY NEUROTROPHIC FACTOR;

AMYOTROPHIC LATERAL SCLEROSIS; BIOTECHNOLOGY; CELL TRANSPLANTATION; CHROMAFFIN CELL; CHRONIC PAIN; CLINICAL TRIAL; ENCAPSULATION; GENETIC ENGINEERING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; LIVER FAILURE; LIVER TRANSPLANTATION; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; TISSUE TRANSPLANTATION;

EID: 0031038479     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(97)90175-6     Document Type: Review

References (61)

1. Lanza RP, Chick WL. Encapsulated cell therapy. Sci Am Science & Medicine 1995;2:16-25.
2. Lanza RP, Chick WL, editors. Pancreatic islet transplantation: volume III. Immunoisolation of pancreatic islets. Austin, Texas: RG Landes, 1994.
3. Lanza RP, Chick WL. Encapsulated cell transplantation. Transplant Rev 1995;9:217-30.
4. Mito M, Sawa M. Hepatocyte transplantation. In: Lanza RP, Chick WL, editors. 1996/97 Yearbook of cell and tissue transplantation. Dordrecht, The Netherlands: Kluwer Academic Press, 1996.
5. Yang MD, Vacanti JP, Ingber DE. Hollow fibers for hepatocyte encapsulation and transplantation: studies of survival and function in rats. Cell Transplant 1994;3:373-85.
6. Jauregui HO, Mullon CJP, Solomon BA. Extracorporeal artificial liver support. In: Lanza RP, Langer R, Chick WL, editors. Principles of tissue engineering. Austin, Texas: Landes/Academic Press, 1996.
7. Eguchi S, Chen S, Rozga J, Demetriou AA. Tissue engineering/ hybrid tissues: liver. In: Lanza RP, Chick WL, editors. 1996/97 Yearbook of cell and tissue transplantation. Dordrecht, The Netherlands: Kluwer Academic Press, 1996.
8. Cai ZH, Shi ZQ, Sherman M, Sun AM. Development and evaluation of a system of microencapsulation of primary rat hepatocytes. Hepatology 1989;10:855-60.
9. Sagen J. Chromaffin cell transplantation. In: Lanza RP, Chick WL, editors. 1996/97 Yearbook of cell and tissue transplantation. Dordrecht, The Netherlands: Kluwer Academic Press, 1996.
10. Roberts HR. The treatment of hemophilia: past tragedy and future promise. N Engl J Med 1989;321:1188-90.
11. Chang PL, Shen N, Westcott AJ. Delivery of recombinant gene products with microencapsulated cells in vivo. Hum Gene Ther 1993;4:433-40.
12. Koo J, Chang TMS. Secretion of erythropoietin from microencapsulated rat kidney cells: preliminary results. Int J Artif Organs 1993;16:557-60.
13. Sun AM. Tissue engineering: parathyroid. In: Lanza RP, Langer R, Chick WL, editors. Principles of tissue engineering. Austin, Texas: RG Landes/Academic Press, 1996.
14. Fu XW, Sun AM. Microencapsulated parathyroid cells as a bioartificial parathyroid: in vivo studies. Transplantation 1989;47: 432-5.
15. Aebischer P, Lysaght MJ. Immunoisolation and cellular xenotransplantation. Xeno 1995;3:43-8.
16. Tresco PA, Winn SR, Aebischer P. Polymer encapsulated neurotransmitter secreting cells: potential treatment for Parkinson's disease. ASAIO J 1992;38:17-23.
17. Freed WJ. Neural transplantation: brain. In: Lanza RP, Chick WL, editors. 1996/97 Yearbook of cell and tissue transplantation. Dordrecht, The Netherlands: Kluwer Academic Press, 1996.
18. Aebischer P, Goddard M, Signore AP, Timpson RL. Functional recovery in hemiparkinsonian primates transplanted with polymer-encapsulated PC12 cells. Exp Neurol 1994;126:151-8.
19. Hoffman D, Breakefield XO, Short MP, et al. Transplantation of a polymer-encapsulated cell line genetically engineered to release NGF. Exp Neurol 1993;122:100-6.
20. Frim DM, Short MP, Rosenberg WS, et al. Local protective effects of nerve growth factor-secreting fibroblasts against excitotoxic lesions in the rat striatum. J Neurosurg 1993;78:267-73.
21. Winn SR, Hammang JP, Emerich DF, et al. Polymer-encapsulated cells genetically modified to secrete human growth factor promote the survival of axotomized septal cholinergic neurons. Proc Natl Acad Sci USA 1994;91:2324-8.
22. Tessler A. Neural transplantation: spinal cord. In: Lanza KP, Chick WL, editors. 1996/97 Yearbook of cell and tissue transplantation. Dordrecht, The Netherlands: Kluwer Academic Press, 1996.
23. Cielinski DA, Humes HD. Tissue engineering of a bioartificial kidney. Biotech Bioeng 1994;43:678-81.
24. Christenson L, Aebischer P, Galletti PM. Encapsulated thymic epithelial cells as a potential treatment for immunodeficiencies. Trans Am Soc Artif Intern Organs 1988;34:681-6.
25. The Diabetes Control and Complication Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
26. Sutherland DER, Gruessner RWG, Gores PF. Pancreas and islet transplantation. Transplant Rev 1994;8:185-206.
27. Kahan BD. Cyclosporine. N Engl J Med 1989;321:1725-38.
28. Gunnarsson R, Klintmalm G, Lundgren G, et al. Deterioration in glucose metabolism in pancreatic transplant recipients given cyclosporin. Lancet 1983;2:571-2.
29. Van Schilfgaarde R, van der Burg MPM, van Suylichem HG, et al. Does cyclosporin influence beta cell function? Transplant Proc 1986;28:1175-6.
30. Lanza RP, Sullivan SJ, Chick WL. Islet transplantation with immunoisolation. Diabetes 1992;41:1503-10.
31. Chick WL, Like AA, Lauris V. Beta cell culture on synthetic capillaries: an artificial endocrine pancreas. Science 1975;187: 847-9.
32. Tze WJ, Wong FC, Chen IM. Implantable artificial endocrine pancreas unit used to restore normoglycemia in the diabetic rat. Nature 1976;264:466-7.
33. Whittemore AD, Chick WL, Galletti PM, et al. Effects of the hybrid artificial pancreas in diabetic rats. Trans Am Soc Artif Intern Organs 1977;13:336-40.
34. Sun AM, Parisius W, Healy GM, et al. The use in diabetic rats and monkeys of artificial capillary units containing cultured islets of Langerhans. Diabetes 1977;26:1136-9.
35. Lanza RP, Solomon BA, Monaco AP, Chick WL. Devices implanted as AV shunts. In: Lanza RP, Chick WL, editors. Pancreatic islet transplantation: volume III. Immunoisolation of pancreatic islets. Austin, Texas: RG Landes, 1994:154-68.
36. Sullivan SJ, Maki T, Borland KM, et al. Biohybrid artificial pancreas: long-term implantation studies in diabetic, pancreatectomized dogs. Science 1991;252:718-21.
37. Maki T, Otsu I, O'Neill JJ, et al. Treatment of diabetes by xenogeneic islets without immunosuppression. Diabetes 1996;45:342-47.
38. Colton CK. Implantable biohybrid aruficial organs. Cell Transplant 1995;4:415-36.
39. Lanza RP, Butler DH, Borland KM, et al. Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Proc Natl Acad Sci USA 1991;88:11100-4.
40. Lanza RP, Borland KM, Lodge P, et al. Treatment of severely diabetic, pancreatectomized dogs using a diffusion-based hybrid pancreas. Diabetes 1992;41:886-9.
41. Lanza RP, Borland KM, Staruk JE, et al. Transplantation of encapsulated canine islets into spontaneously diabetic BB/Wor rats without immunosuppression. Endocrinology 1992;131:637-42.
42. Lanza RP, Beyer AM, Staruk JE, Chick WL. Biohybrid artificial pancreas: longterm function of discordant islet xenografts in streptozotocin diabetic rats. Transplantation 1993;56:1067-72.
43. Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980;210:908-10.
44. O'Shea GM, Goosen MFA, Sun AM. Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane. Biochim Biophys Acta 1984;804:133-6.
45. Calafiore R, Janjic D, Koh N, Alejandro R. Transplantation of microencapsulated canine islets into NOD mice: prolongation of survival with superoxide dismutase and catalase. Clin Res 1987; 35:499A.
46. Ricker A, Bhatia V, Bonner-Weir S, Eisenbarth G. Microencapsulated xenogeneic islet grafts in NOD mouse; dexamethasone and inflammatory response. Cold Spring Harb Symp 1987; October:53A.
47. Lanza RP, Kühtreiber WM, Ecker D, et al. Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres. Transplantation 1995;59:1377-84.
48. Lanza RP, Ecker D, Kühtreiber WM, et al. A simple method for transplanting discordant islets into rats using alginate gel spheres. Transplantation 1995;59:1486-7.
49. Adaniya GK, Rawlins RG, Quigg JM, et al. First pregnancies and live births from transfer of sodium alginate encapsulated embryos in a rodent model. Fertil Steril 1993;59:652-5.
50. Al-Shamkhani A, Duncan R. Radioiodination of alginate via covalently-bound tyrosinamide allows monitoring of its fate in vivo. J Bioact Compat Polymers 1995;10:4-13.
51. Soon-Shiong P, Feldman E, Nelson R, et al. Long-term reversal of diabetes by the injection of immunoprotected islets. Proc Natl Acad Sci USA 1993;90:5843-7.
52. Soon-Shiong P, Heintz RE, Merideth N, et al. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 1994;143:950-1.
53. Aebischer P, Buchser E, Joseph JM, et al. Transplantation in humans of encapsulated xenogeneic cells without immunosuppression. Transplantation 1994;58:1275-7.
54. Ezzell C. Tissue engineering and the human body shop: encapsulated-cell transplants enter the clinic. JNIH Research 1995;7:47-51.
55. Neuzil D, Rozga J, Moscioni AD, et al. Use of a bioartifidal liver in a patient with acute liver insufficiency. Surgery 1993;113: 340-3.
56. Hering BJ, Wahoff DC, Sutherland DER. Clinical islet transplantation. In: Lanza RP, Chick WL, editors. 1996/97 Yearbook of cell and tissue transplantation. Dordrecht, The Netherlands: Kluwer, 1996.
57. Bretzel RG, Hering BJ, Schultz AO, et al. International islet transplant registry report. In: Lanza RP, Chick WL, editors. 1996/97 Yearbook of cell and tissue transplantation. Dordrecht. The Netherlands: Kluwer Academic Press, 1996.
58. Sendtner M, Schmalbruch H, Stockli KA, et al. Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant neuronopathy. Nature 1992;358:502-4.
59. Sagot Y, Tan SA, Baetge E, et al. Polymer encapsulated cell lines genetically engineered to release ciliary neurotrophic factor can slow down progressive motor neuropathy in the mouse. Eur J Neurosci 1995;7:1313-22.
60. Rozga J, Morsiani E, LePage E, et al. Isolated hepatocytes in a bioartificial liver: a single group view and experience. Biotech Bioeng 1994;43:645-53.
61. Rozga J, Williams F, Ro MS, et al. Development of a bioartificial liver: properties and function of a hollow-fiber module inoculated with liver cells. Hepatology 1993;17:258-65.